- Home
- SONN vs ISPC Comparison
SONN vs ISPC Comparison
Compare SONN & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- ISPC
- Stock Information
- Founded
- SONN N/A
- ISPC 2009
- Country
- SONN United States
- ISPC United States
- Employees
- SONN N/A
- ISPC N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- SONN Health Care
- ISPC Health Care
- Exchange
- SONN Nasdaq
- ISPC Nasdaq
- Market Cap
- SONN 3.8M
- ISPC 3.1M
- IPO Year
- SONN N/A
- ISPC 2021
- Fundamental
- Price
- SONN $1.11
- ISPC $0.86
- Analyst Decision
- SONN Strong Buy
- ISPC
- Analyst Count
- SONN 1
- ISPC 0
- Target Price
- SONN $20.00
- ISPC N/A
- AVG Volume (30 Days)
- SONN 46.3K
- ISPC 51.8K
- Earning Date
- SONN 08-13-2025
- ISPC 08-05-2025
- Dividend Yield
- SONN N/A
- ISPC N/A
- EPS Growth
- SONN N/A
- ISPC N/A
- EPS
- SONN N/A
- ISPC N/A
- Revenue
- SONN $1,000,000.00
- ISPC $8,058,631.00
- Revenue This Year
- SONN $5,376.22
- ISPC $35.93
- Revenue Next Year
- SONN N/A
- ISPC N/A
- P/E Ratio
- SONN N/A
- ISPC N/A
- Revenue Growth
- SONN 978.39
- ISPC N/A
- 52 Week Low
- SONN $1.08
- ISPC $0.86
- 52 Week High
- SONN $10.02
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- SONN 38.81
- ISPC 26.71
- Support Level
- SONN $1.11
- ISPC $0.97
- Resistance Level
- SONN $1.25
- ISPC $1.01
- Average True Range (ATR)
- SONN 0.06
- ISPC 0.08
- MACD
- SONN 0.00
- ISPC -0.03
- Stochastic Oscillator
- SONN 0.00
- ISPC 1.05
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.